Tilaknagar Industries Q4FY26 net revenue rises 148% to INR 949 crore

2 min read     Updated on 03 Jun 2026, 03:29 AM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Tilaknagar Industries Ltd. reported a 148% year-on-year increase in net revenue to INR 949 crore for Q4FY26, driven by the inclusion of the Imperial Blue business division. The company achieved an overall volume of 8 million cases during the quarter, with Imperial Blue contributing 4.6 million cases. EBITDA for the quarter stood at INR 155 crore, reflecting a 97% growth with a margin of 16.3%. For the full year FY26, revenues grew by 70% to reach INR 2,346 crore, while EBITDA increased by 64% to INR 419 crore.

powered bylight_fuzz_icon
41869966

*this image is generated using AI for illustrative purposes only.

Tilaknagar Industries Ltd. reported a 148% year-on-year increase in net revenue to INR 949 crore for Q4FY26, driven by the inclusion of the Imperial Blue business division. The company achieved an overall volume of 8 million cases during the quarter, with Imperial Blue contributing 4.6 million cases. EBITDA for the quarter stood at INR 155 crore, reflecting a 97% growth with a margin of 16.3%. For the full year FY26, revenues grew by 70% to reach INR 2,346 crore, while EBITDA increased by 64% to INR 419 crore.

The company disclosed the transcript of its earnings conference call held on May 30, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Amit Dahanukar, Chairman and Managing Director, highlighted that Mansion House Brandy crossed the volume benchmark of 10 million cases in FY26, cementing its position as India's largest Prestige and Above (P&A) brandy.

Financial Performance

Management noted a change in presentation regarding revenue recognition, where selling expenses are now deducted from gross revenue rather than shown under other expenses. This change negatively impacts reported revenue and gross margins but positively impacts EBITDA and PAT margins. Net Sales Realisation (NSR) increased by 5.4% to INR 1,177 per case in Q4FY26 from INR 1,116 per case in Q4FY25.

Metric Q4FY26 YoY Growth
Net Revenue INR 949 crore 148%
EBITDA INR 155 crore 97%
EBITDA Margin 16.3% -
Overall Volume 8 million cases 135%
FY26 Revenue INR 2,346 crore 70%
FY26 EBITDA INR 419 crore 64%

Operational Highlights and Guidance

The company received government approval to expand capacity at its Prag facility in Andhra Pradesh from 6 lakh cases per annum to 36 lakh cases per annum, entailing an investment of INR 59 crore. This expansion is expected to generate savings of INR 10 crore per annum in bottling costs. On the integration front, 75% of the Imperial Blue business has exited the Third-Party Supply and Manufacturing Agreement (TSMA), with the remaining transition expected by March 2027.

For FY27, the company expects high-single digit to low-double digit volume growth for the combined business. It targets consolidated EBITDA margins of 16%-18% over the next 24 to 36 months. The Board of Directors has recommended a dividend of INR 1 per share for FY25-'26. As on March 31, 2026, gross debt stood at INR 2,295 crore and net debt at INR 1,911 crore.

Historical Stock Returns for Tilaknagar Industries

1 Day5 Days1 Month6 Months1 Year5 Years
-0.81%-6.53%-10.11%-9.51%+16.70%+1,023.01%

How will Tilaknagar Industries manage its net debt of INR 1,911 crore, and what is the timeline for meaningful deleveraging given its current EBITDA trajectory?

With the remaining 25% of Imperial Blue still under the TSMA agreement, what operational or regulatory risks could delay the full transition beyond the March 2027 target?

Can Mansion House Brandy sustain its position as India's largest P&A brandy amid intensifying competition from multinational spirits companies expanding in the Indian market?

like15
dislike

Tilaknagar FY26 revenue rises 69.9% to ₹2,346 crore

2 min read     Updated on 02 Jun 2026, 06:12 AM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Tilaknagar Industries Limited reported a consolidated revenue of ₹2,346 crore for FY26, a 69.9% increase driven by the Imperial Blue acquisition, achieving a record volume of 20 million cases. The company posted a net profit of ₹299 crore for the year, while Q4 revenue surged 147.5% to ₹949 crore. The Board recommended a ₹1 per share dividend and approved the re-appointment of Amit Dahanukar as CMD. Statutory auditors issued a qualified opinion regarding the lack of impairment assessment for an ENA plant.

powered bylight_fuzz_icon
41325187

*this image is generated using AI for illustrative purposes only.

Tilaknagar Industries Limited reported a consolidated revenue of ₹2,346 crore for the financial year ended March 31, 2026, a 69.9% increase from the previous year, primarily driven by the acquisition of the Imperial Blue business division. The company achieved a record volume of approximately 20 million cases in FY26. For the quarter ended March 31, 2026, revenue surged 147.5% to ₹949 crore, with volumes reaching 8 million cases. The Board of Directors, in its meeting held on May 29, 2026, approved the audited financial results for the quarter and year ended March 31, 2026.

Financial Performance

Particulars Q4 FY26 (₹ in Cr) Q4 FY25 (₹ in Cr) FY26 (₹ in Cr) FY25 (₹ in Cr)
Net Revenue from Operations 949 384 2,346 -
EBITDA 155 78 419 -
PAT* 82 - 299 -

*Profit after tax excluding exceptional items and amortization on intangible assets related to acquisition.

The statutory auditors, M/s. Harshil Shah & Company, expressed a qualified opinion on the consolidated annual financial results. The qualification arose because the Holding Company did not carry out an impairment assessment of one of the ENA plants that is not in operation, as required by Indian Accounting Standard (Ind AS) 36, despite indications of impairment.

Corporate Developments

The Board recommended a dividend of ₹1 per equity share having a face value of ₹10 each (i.e., 10%) for FY26, subject to the approval of shareholders. Additionally, the Board approved the re-appointment of Amit Dahanukar as Chairman and Managing Director for a period of three years from November 07, 2026. The Board also approved the incorporation of a wholly-owned subsidiary in Nigeria and a composite scheme of amalgamation for two wholly-owned subsidiaries, Punjabexpo Breweries Private Limited and Vahni Distilleries Private Limited, with the company.

Mansion House Brandy surpassed 10 million cases in sales in FY26. Prag Distillery received government approval for starting operations at its expanded capacity in Andhra Pradesh. The company's luxury portfolio, House of TI, won four awards at the London Spirits Competition 2026.

Regulatory Disclosure

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the earnings conference call held on May 30, 2026, to discuss the Q4 and FY26 results is available on the company's website.

Historical Stock Returns for Tilaknagar Industries

1 Day5 Days1 Month6 Months1 Year5 Years
-0.81%-6.53%-10.11%-9.51%+16.70%+1,023.01%

How does the company plan to address the impairment assessment required by Ind AS 36 for the non-operational ENA plant following the auditors' qualified opinion?

What revenue synergies and cost efficiencies does Tilaknagar Industries expect to realize in the coming year following the integration of the Imperial Blue business division?

How will the newly approved expanded capacity at the Prag Distillery in Andhra Pradesh contribute to volume growth and market reach in the next fiscal year?

like17
dislike

More News on Tilaknagar Industries

1 Year Returns:+16.70%